查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702116

2025 年至 2033 年體內 CRO 市場報告，按類型（囓齒動物、非囓齒動物）、GLP 類型（非 GLP、GLP 毒理學）、適應症（自體免疫/發炎疾病、疼痛管理、腫瘤學、中樞神經系統疾病、糖尿病、肥胖症等）和地區分類

In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024年全球體內CRO市場規模達53億美元。展望未來， IMARC Group預計到2033年市場規模將達到98億美元，2025-2033年期間的成長率（CAGR）為6.76%。全球範圍內慢性病的日益普及以及製藥公司不斷增加的研發支出正在推動市場的成長。

體內合約研究組織（CRO）是根據合約進行廣泛生物製藥研究的機構。他們透過提供外包服務來支援製藥和生物技術公司配製有效的藥物、疫苗和醫療設備。與體外CRO相比，體內CRO是在生物體內進行的研究，透過人體臨床試驗來評估藥物的安全性和有效性，而不是對切除的細胞和組織進行檢查。它們有助於研究機構管理複雜的醫學測試，以最低的成本開發有效的藥物，並透過避免招聘、籌款和臨床準備造成的延誤來最佳化工作流程。因此，體內 CRO 在疼痛管理、腫瘤學以及治療中樞神經系統 (CNS) 損傷和其他疾病方面有廣泛的應用。目前，它們分為囓齒動物類型和非囓齒動物類型。

體內CRO市場趨勢：

各種心血管疾病的發生率不斷上升，尤其是在老年人群中，對有效藥物和新型腫瘤診斷和治療療法的需求不斷成長，是推動市場成長的主要因素。此外，合約研究、開發和製造組織 (CRDMO) 對臨床規模生產活性藥物成分 (API) 的需求不斷成長，以及對生物相似藥而非單株抗體形式的傾向轉變，也是其他促進成長的因素。此外，日益加劇的健康問題促使生技公司與 CRO 合作設計有效的新型疫苗，尤其是在 COVID-19 大流行期間，這有助於市場成長。此外，在臨床前活動期間廣泛利用體內 CRO 進行毒理學和藥物動力學研究正在推動市場成長。除此之外，生物等效性的出現、學名藥的快速成長、專利的不斷到期以及個性化藥物設計的持續研發活動正在為市場創造積極的前景。

本報告回答的關鍵問題

  • 2024 年全球體內 CRO 市場規模？ 2025-2033年全球體內CRO市場的預期成長率是多少？
  • 推動全球體內 CRO 市場發展的關鍵因素有哪些？
  • COVID-19 對全球體內 CRO 市場有何影響？
  • 全球體內 CRO 市場依類型分為哪些類型？
  • 根據 GLP 類型，全球體內 CRO 市場如何分佈？
  • 根據適應症，全球體內 CRO 市場如何分類？
  • 全球體內 CRO 市場的關鍵區域有哪些？
  • 全球體內 CRO 市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球體內CRO市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 囓齒動物
    • 關鍵部分
      • 大鼠
      • 老鼠
      • 其他
  • 不囓齒類動物

第7章：市場區隔：依 GLP 類型

  • 非GLP
    • 關鍵部分
      • 內部
      • 外包
  • GLP毒理學
    • 關鍵部分
      • 內部
      • 外包

第8章：市場區隔：依指標

  • 自體免疫/發炎狀況
    • 關鍵部分
      • 類風濕關節炎
      • 多發性硬化症
      • 骨關節炎
      • 急躁性腸症候群
      • 其他
  • 疼痛管理
    • 關鍵部分
      • 慢性疼痛
      • 急性疼痛
  • 腫瘤學
    • 關鍵部分
      • 血癌
      • 實體腫瘤
      • 其他
  • 中樞神經系統疾病
    • 關鍵部分
      • 癲癇
      • 帕金森氏症
      • 亨廷頓舞蹈症
      • 中風
      • 創傷性腦損傷
      • 肌萎縮側索硬化症
      • 肌肉再生
      • 其他
  • 糖尿病
  • 肥胖
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Charles River Laboratories International Inc.
    • Evotec SE
    • ICON plc
    • Iris Pharma (ABIONYX Pharma)
    • Labcorp Drug Development (Laboratory Corporation of America Holdings)
    • North American Science Associates LLC
    • Parexel International Corporation
    • Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.)
    • Pronexus Analytical AB
    • Syneos Health
    • WuXi AppTec
Product Code: SR112025A6267

The global in-vivo CRO market size reached USD 5.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 6.76% during 2025-2033. The growing prevalence of chronic diseases worldwide and the increasing R&D expenditure by pharmaceutical companies are propelling the market growth.

In-vivo contract research organizations (CROs) are institutions that conduct extensive biopharmaceutical research on a contractual basis. They support pharmaceutical and biotechnology companies in formulating effective drugs, vaccines, and medical devices by providing outsourcing services. As compared to in-vitro CRO, in-vivo CRO deals with the research performed within the living organism and conducts human clinical trials to assess the safety and efficacy of the drugs instead of organizing examinations on removed cells and tissues. They aid research institutions in managing complex medical testing, developing effective medications at minimal costs, and optimizing workflow by avoiding delays caused by hiring, fundraising, and clinical preparations. As a result, in-vivo CRO finds extensive application in pain management, oncology, and treating central nervous system (CNS) injuries and other disorders. Currently, they are bifurcated into rodent- and non-rodent-based types.

In-vivo CRO Market Trends:

The increasing prevalence of various cardiovascular ailments, especially amongst the geriatric population, and the growing need for effective medications and novel oncology-based therapies for diagnosis and treatment are primarily driving the market growth. Additionally, the rising demand for clinical-scale manufacturing of active pharmaceutical ingredients (APIs) by contract research, development, and manufacturing organizations (CRDMOs) and the shifting inclination toward biosimilars over format monoclonal antibodies are acting as other growth-inducing factors. Furthermore, the fueling health concerns have prompted biotechnology companies to engineer effective novel vaccines in collaboration with CRO, especially during the COVID-19 pandemic, which is contributing to the market growth. Moreover, the extensive utilization of in-vivo CRO to perform toxicology and pharmacokinetic studies during preclinical activities is impelling the market growth. Apart from this, the advent of bioequivalence, rapid growth in generics, ongoing patent expirations, and continuous research and development (R&D) activities to engineer personalized medicines are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Type:

  • Rodent
  • Rats
  • Mice
  • Others
  • Non-Rodent

Breakup by GLP Type:

  • Non-GLP
  • In House
  • Outsourcing
  • GLP Toxicology
  • In House
  • Outsourcing

Breakup by Indication:

Autoimmune/Inflammation Conditions

Rheumatoid Arthritis

Multiple Sclerosis

Osteoarthritis

Irritable Bowel Syndrome

Others

Pain Management

Chronic Pain

Acute Pain

Oncology

Blood Cancer

Solid Tumor

Others

CNS Conditions

Epilepsy

Parkinson's Disease

Huntington's Disease

Stroke

Traumatic Brain Injury

ALS

Muscle Regeneration

Others

Diabetes

Obesity

Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories International Inc., Evotec SE, ICON plc, Iris Pharma (Abionyx Pharma), Labcorp Drug Development (Laboratory Corporation of America Holdings), North American Science Associates LLC, Parexel International Corporation, Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.), Pronexus Analytical AB, Syneos Health and WuXi AppTec.

Key Questions Answered in This Report

  • 1.What was the size of the global in-vivo CRO market in 2024?
  • 2.What is the expected growth rate of the global in-vivo CRO market during 2025-2033?
  • 3.What are the key factors driving the global in-vivo CRO market?
  • 4.What has been the impact of COVID-19 on the global in-vivo CRO market?
  • 5.What is the breakup of the global in-vivo CRO market based on the type?
  • 6.What is the breakup of the global in-vivo CRO market based on the GLP type?
  • 7.What is the breakup of the global in-vivo CRO market based on indication?
  • 8.What are the key regions in the global in-vivo CRO market?
  • 9.Who are the key players/companies in the global in-vivo CRO market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global In-vivo CRO Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Rodent
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Rats
      • 6.1.2.2 Mice
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Non-Rodent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by GLP Type

  • 7.1 Non-GLP
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 In House
      • 7.1.2.2 Outsourcing
    • 7.1.3 Market Forecast
  • 7.2 GLP Toxicology
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 In House
      • 7.2.2.2 Outsourcing
    • 7.2.3 Market Forecast

8 Market Breakup by Indication

  • 8.1 Autoimmune/Inflammation Conditions
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Rheumatoid Arthritis
      • 8.1.2.2 Multiple Sclerosis
      • 8.1.2.3 Osteoarthritis
      • 8.1.2.4 Irritable Bowel Syndrome
      • 8.1.2.5 Others
    • 8.1.3 Market Forecast
  • 8.2 Pain Management
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Chronic Pain
      • 8.2.2.2 Acute Pain
    • 8.2.3 Market Forecast
  • 8.3 Oncology
    • 8.3.1 Market Trends
    • 8.3.2 Key Segments
      • 8.3.2.1 Blood Cancer
      • 8.3.2.2 Solid Tumor
      • 8.3.2.3 Others
    • 8.3.3 Market Forecast
  • 8.4 CNS Conditions
    • 8.4.1 Market Trends
    • 8.4.2 Key Segments
      • 8.4.2.1 Epilepsy
      • 8.4.2.2 Parkinson's Disease
      • 8.4.2.3 Huntington's Disease
      • 8.4.2.4 Stroke
      • 8.4.2.5 Traumatic Brain Injury
      • 8.4.2.6 ALS
      • 8.4.2.7 Muscle Regeneration
      • 8.4.2.8 Others
    • 8.4.3 Market Forecast
  • 8.5 Diabetes
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Obesity
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Charles River Laboratories International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Evotec SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 ICON plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Iris Pharma (ABIONYX Pharma)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Labcorp Drug Development (Laboratory Corporation of America Holdings)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 North American Science Associates LLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Parexel International Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Pronexus Analytical AB
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Syneos Health
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 WuXi AppTec
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: In-vivo CRO Market: Major Drivers and Challenges
  • Figure 2: Global: In-vivo CRO Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: In-vivo CRO Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: In-vivo CRO Market: Breakup by Type (in %), 2024
  • Figure 5: Global: In-vivo CRO Market: Breakup by GLP Type (in %), 2024
  • Figure 6: Global: In-vivo CRO Market: Breakup by Indication (in %), 2024
  • Figure 7: Global: In-vivo CRO Market: Breakup by Region (in %), 2024
  • Figure 8: Global: In-vivo CRO (Rodent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: In-vivo CRO (Rodent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: In-vivo CRO (Non-Rodent) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: In-vivo CRO (Non-Rodent) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: In-vivo CRO (Non-GLP) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: In-vivo CRO (Non-GLP) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: In-vivo CRO (GLP Toxicology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: In-vivo CRO (GLP Toxicology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: In-vivo CRO (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: In-vivo CRO (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: In-vivo CRO (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: In-vivo CRO (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: In-vivo CRO (CNS Conditions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: In-vivo CRO (CNS Conditions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: In-vivo CRO (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: In-vivo CRO (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: In-vivo CRO (Obesity) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: In-vivo CRO (Obesity) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: In-vivo CRO (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: In-vivo CRO (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: In-vivo CRO Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: In-vivo CRO Industry: SWOT Analysis
  • Figure 80: Global: In-vivo CRO Industry: Value Chain Analysis
  • Figure 81: Global: In-vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In-vivo CRO Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: In-vivo CRO Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: In-vivo CRO Market Forecast: Breakup by GLP Type (in Million USD), 2025-2033
  • Table 4: Global: In-vivo CRO Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 5: Global: In-vivo CRO Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: In-vivo CRO Market: Competitive Structure
  • Table 7: Global: In-vivo CRO Market: Key Players